Figure 14. Progression-free survival according to involved serum free-light chain levels below the lower limit of normality (green) on (A) days 28 and (B) 100.
No takes yet. Share an insight, caveat, or question.
Oliver‐Caldés et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: